Read More Pharma Industry News BioCryst Pharmaceuticals gains Japan pediatric approval as ORLADEYO revenue momentum builds Japan expands ORLADEYO to younger children as BioCryst Pharmaceuticals builds its growing global hereditary angioedema franchise. bySoujanya RaviAugust 27, 2026